These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2990133)

  • 1. Responses of patients with Bartter's syndrome to angiotensin III and angiotensin II-(3-8)-hexapeptide.
    Kono T; Ikeda F; Taniguchi A; Imura H; Oseko F; Yoshioka M; Khosla MC
    Acta Endocrinol (Copenh); 1985 Jun; 109(2):249-53. PubMed ID: 2990133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of a heptapeptide angiotensin analog on aldosterone secretion in the rabbit.
    Neusy AJ; Pessah M; Steele JM; Lowenstein J
    Kidney Int; 1980 Jan; 17(1):66-73. PubMed ID: 6990089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological activity of des-asp1-des-arg2-angiotensin II in man.
    Kono T; Ikeda F; Oseko F; Ohmori Y; Nakano R; Muranaka H; Taniguchi A; Imura H; Khosla MC; Bumpus FM
    Acta Endocrinol (Copenh); 1982 Apr; 99(4):577-84. PubMed ID: 7041505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of angiotensin III action by DES-ASP1-,ILEU8-angiotensin II in man.
    Kono T; Ikeda F; Oseko F; Nanno M; Imura H; Endo J
    Acta Endocrinol (Copenh); 1978 Feb; 87(2):359-66. PubMed ID: 580136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological activities of angiotensin II-(1-6)-hexapeptide and angiotensin II-(1-7)-heptapeptide in man.
    Kono T; Taniguchi A; Imura H; Oseko F; Khosla MC
    Life Sci; 1986 Apr; 38(16):1515-9. PubMed ID: 3702589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of indomethacin upon the renin--angiotensin system in patients with Bartter's syndrome.
    Vierhapper H; Waldhäusl W
    Eur J Clin Invest; 1980 Apr; 10(2 Pt 1):119-24. PubMed ID: 6780358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atrial natriuretic peptide levels during angiotensin infusion and indomethacin administration are consistent with angiotensin-mediated regulation in man.
    Klemm SA; Tunny TJ; Gordon RD
    J Hypertens Suppl; 1987 Dec; 5(5):S75-8. PubMed ID: 2965235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracerebroventricularly infused [D-Arg1]angiotensin III, is superior to [D-Asp1]angiotensin II, as a pressor agent in rats.
    Wright JW; Roberts KA; Cook VI; Murray CE; Sardinia MF; Harding JW
    Brain Res; 1990 Apr; 514(1):5-10. PubMed ID: 2357530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological activity of des-Asp1-,Ileu8-angiotensin II (Ileu8-angiotensin III) in man.
    Kono T; Oseko F; Ikeda F; Nanno M; Endo J
    J Clin Endocrinol Metab; 1976 Oct; 43(4):940-3. PubMed ID: 977730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of angiotensin III on blood pressure, renin-angiotensin-aldosterone system in normal and hypertensive subjects.
    Suzuki S; Doi Y; Aoi W; Kuramochi M; Hashiba K
    Jpn Heart J; 1984 Jan; 25(1):75-85. PubMed ID: 6376863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are angiotensin receptors in vascular smooth muscles a homogeneous population?
    Tabrizchi R; Pang CC
    Eur J Pharmacol; 1987 Oct; 142(3):359-66. PubMed ID: 3428350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. (7-Ile) angiotensin III: a relatively selective antagonist of angiotensin steroidogenesis.
    Campbell WB; Schmitz JM
    Eur J Pharmacol; 1979 Mar; 54(3):209-16. PubMed ID: 218823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bartter's syndrome: effect of indomethacin on prostaglandins, urinary kallikrein, renin-angiotensin-aldosterone system, and the response to angiotensin II antagonist.
    Sasaki H; Kawasaki T; Okumura M; Asano T; Abe K; Arakawa K
    Endocrinol Jpn; 1980 Aug; 27(4):417-29. PubMed ID: 7007031
    [No Abstract]   [Full Text] [Related]  

  • 14. Attenuation of angiotensin II- and III-induced aldosterone release by prostaglandin synthesis inhibitors.
    Campbell WB; Gomez-Sanchez CE; Adams BV; Schmitz JM; Itskovitz HD
    J Clin Invest; 1979 Dec; 64(6):1552-7. PubMed ID: 500824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Sar1-ala8-angiotensin II on blood pressure and renin in Bartter's syndrome, before and after treatment with prostaglandin synthetase inhibitors.
    Rudin A; Aurell M; Hansson L; Westberg G
    Scand J Clin Lab Invest; 1979 Oct; 39(6):543-50. PubMed ID: 119300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of the kallikrein-kinin system and vascular reactivity in Bartter's syndrome.
    Rodriguez-Portales JA; Lopez-Moreno JM; Mahana D
    Hypertension; 1985; 7(6 Pt 1):1017-22. PubMed ID: 2416684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin peptides and prostaglandin E2 synthesis: modulation of neurogenic responses in the rabbit vas deferens.
    Saye J; Binder SB; Trachte GJ; Peach MJ
    Endocrinology; 1986 Nov; 119(5):1895-903. PubMed ID: 3464412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin antagonists with increased specificity for the renal vasculature.
    Taub KJ; Caldicott WJ; Hollenberg NK
    J Clin Invest; 1977 Mar; 59(3):528-35. PubMed ID: 190270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relative biological activities of Asn1-,Val5-angiotensin II, Ile5-angiotensin II and Sar1-angiotensin II in man.
    Kono T; Taniguchi A; Imura H; Oseko F; Khosla MC
    Life Sci; 1985 Jul; 37(4):365-9. PubMed ID: 3892218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of diltiazem hydrochloride on pressor and steroidogenic actions of angiotensins and norepinephrine in man.
    Ikeda F; Kono T; Oseko F; Imura H; Endo J
    Endocrinol Jpn; 1980 Dec; 27(6):779-84. PubMed ID: 7262036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.